In conclusion, based on high-dose animal and in vitro studies, curcumin appears to be a promising therapeutic agent to decrease the risk of T2DM, CVD and neurodegenerative disease by improving glucose homeostasis, lipid metabolism, endothelial function and insulin signalling, and by inhibiting Aβ aggregation. This evidence concerns the gene INS and neurodegenerative disease.